On Friday, Canopy Growth Corporation (NASDAQ: CGC) opened lower -16.97% from the last session, before settling in for the closing price of $1.65. Price fluctuations for CGC have ranged from $0.77 to $5.80 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 32.50% over the last five years. Company’s average yearly earnings per share was noted 88.49% at the time writing. With a float of $308.77 million, this company’s outstanding shares have now reached $311.99 million.
Canopy Growth Corporation (CGC) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Canopy Growth Corporation is 1.03%, while institutional ownership is 6.92%. The most recent insider transaction that took place on Sep 29 ’25, was worth 24,770. In this transaction Director of this company sold 15,677 shares at a rate of $1.58, taking the stock ownership to the 103,387 shares. Before that another transaction happened on Sep 29 ’25, when Company’s Director sold 2,216 for $1.58, making the entire transaction worth $3,501. This insider now owns 43,464 shares in total.
Canopy Growth Corporation (CGC) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -1.23 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.32) by -0.9. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 88.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 69.37% during the next five years compared to 32.50% growth over the previous five years of trading.
Canopy Growth Corporation (NASDAQ: CGC) Trading Performance Indicators
Check out the current performance indicators for Canopy Growth Corporation (CGC). In the past quarter, the stock posted a quick ratio of 2.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.03, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.26 in one year’s time.
